FIGURE
Fig. 3
- ID
- ZDB-FIG-221101-35
- Publication
- Angom et al., 2021 - LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 3
LCC-09 inhibits activation of NFκB and STAT1, and ROS generation in endothelial cells. HUVECs were pre-treated with LCC-09 and control DMSO for 30 mins at the indicated concentrations and then stimulated with TNFα (5 ng/mL). (A and B) Cell lysates were subjected to Western blotting. (C) ChIP was performed to examine the binding of NFκB to E-selectin promoter 2 h after TNFα stimulation. (D and E) Cells were stained with Cellrox Green and imaged (D). Fluorescent intensity was measured with a SpectraMax plate reader and compared (E) 30 mins after TNFα stimulation. *p<0.05; **p<0.01; ***p<0.001. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J Inflamm Res